Boris M. Baranovski
Beersheba, D, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action.
Journal: Cellular immunology
Published: March 15, 2020
MitoTimer-based high-content screen identifies two chemically-related benzothiophene derivatives that enhance basal mitophagy.
Journal: The Biochemical journal
Published: September 24, 2019
Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients.
Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)
Published: February 07, 2019
Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.
Journal: Frontiers in immunology
Published: January 30, 2018
Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 25, 2016
Diluted serum from calorie-restricted animals promotes mitochondrial β-cell adaptations and protect against glucolipotoxicity.
Journal: The FEBS journal
Published: April 27, 2015
T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin.
Journal: BioMed research international
Published: April 03, 2015
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.
Journal: Clinical and experimental immunology
Published: October 27, 2014
Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses.
Journal: The Journal of infectious diseases
Published: September 01, 2014
Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo.
Journal: Frontiers in immunology
Published: July 04, 2013
Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.
Journal: PloS one
Published: November 27, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026